menu
    • menu

    Company profile for BioEclipse Therapeutics

    NEW Drugs in Dev: 1
    Granules India Limited has high volume world-class facilities for APIs, PFIs, & FDFs, serving customers in over 80 countries.

    Virtual Booth

    Contact Supplier

    Lupin Manufacturing Solutions – delivering high-quality APIs & end-to-end CDMO services for faster, cost-effective drug development.

    Virtual Booth

    Contact Supplier

    Mission CDMO team brings reliability, resourcefulness, & responsiveness in executing your development project.

    Virtual Booth

    Contact Supplier

    Egis is a Hungarian generic pharma company with 110 years history. Our activities incorporate all areas of the pharma value chain.

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-2026-02-09

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    BioEclipse Therapeutics™ is a clinical-stage oncology company that uses its proprietary technology to develop the next generation of immuno-oncology therapeutics. Foundationally, we have harnessed a refined understanding of the human immune system, gaining insights into the reasons the body’s defense system so often turns a blind eye to the presence of cancerous cells and tumors. In response, BioEclipse Therapeutics™ p...
    BioEclipse Therapeutics™ is a clinical-stage oncology company that uses its proprietary technology to develop the next generation of immuno-oncology therapeutics. Foundationally, we have harnessed a refined understanding of the human immune system, gaining insights into the reasons the body’s defense system so often turns a blind eye to the presence of cancerous cells and tumors. In response, BioEclipse Therapeutics™ pairs activated immune cells with an adapted oncolytic virus that selectively infects and kills malignant cells.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    BioEclipse TherapeuticsUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    329 Oyster Point Blvd. 3rd Floor S. San Francisco, CA 94080
    Telephone
    Telephone
    408.809.1030
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.bioeclipse.com/
    Linkedin
    Linkedin
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Clinical Outsourcing

    Clinical Outsourcing

    Not Confirmed

    envelop Contact Supplier

    Clinical Outsourcing

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    BioEclipse Tx Awarded Almost $8M Grant by CIRM to Fund Ongoing PI CRX100 Trial
    BioEclipse Tx Awarded Almost $8M Grant by CIRM to Fund Ongoing PI CRX100 Trial

    26 Apr 2022

    // PRNEWSWIRE

    https://www.prnewswire.com/news-releases/bioeclipse-therapeutics-awarded-almost-8-million-grant-by-california-institute-for-regenerative-medicine-cirm-to-fund-ongoing-phase-1-crx100-cancer-immunotherapy-clinical-trial-301532795.html

    PRNEWSWIRE
    26 Apr 2022
    Share Share
    BioEclipse Therapeutics Appoints New Board Member and Names Interim CFO
    BioEclipse Therapeutics Appoints New Board Member and Names Interim CFO

    26 Jan 2022

    // PRNEWSWIRE

    https://www.prnewswire.com/news-releases/bioeclipse-therapeutics-appoints-new-board-member-and-names-interim-cfo-301468229.html

    PRNEWSWIRE
    26 Jan 2022
    Share Share
    BioEclipse to Present at Virtual H.C. Wainwright 23rd Annual Conference
    BioEclipse to Present at Virtual H.C. Wainwright 23rd Annual Conference

    10 Sep 2021

    // PRNEWSWIRE

    https://www.prnewswire.com/news-releases/bioeclipse-therapeutics-to-present-at-virtual-hc-wainwright-23rd-annual-global-healthcare-conference-301373551.html

    PRNEWSWIRE
    10 Sep 2021
    Share Share
    BioEclipse Initiates Enrollment in Phase 1 Dose-Escalation Trial for CRX100
    BioEclipse Initiates Enrollment in Phase 1 Dose-Escalation Trial for CRX100

    19 Jan 2021

    // PRNEWSWIRE

    https://www.prnewswire.com/news-releases/bioeclipse-initiates-enrollment-in-phase-1-dose-escalation-clinical-trial-for-crx100-at-honorhealth-research-institute-301210569.html

    PRNEWSWIRE
    19 Jan 2021
    Share Share
    BioEclipse Initiates Enrollment in Phase 1 Dose-Escalation Trial for CRX100
    BioEclipse Initiates Enrollment in Phase 1 Dose-Escalation Trial for CRX100

    22 Dec 2020

    // PRNEWSWIRE

    https://www.prnewswire.com/news-releases/bioeclipse-initiates-enrollment-in-phase-1-dose-escalation-clinical-trial-for-crx100-301196556.html

    PRNEWSWIRE
    22 Dec 2020
    Share Share
    BioEclipse Therapeutics to Participate in Sachs Annual Biotech in EuropeForum
    BioEclipse Therapeutics to Participate in Sachs Annual Biotech in EuropeForum

    18 Sep 2020

    // BIOSPACE

    https://www.biospace.com/article/releases/bioeclipse-therapeutics-to-participate-in-the-sachs-annual-biotech-in-europe-forum/

    BIOSPACE
    18 Sep 2020
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search